Package 0409-5093-11
Brand: tazicef
Generic: ceftazidimePackage Facts
Identity
Package NDC
0409-5093-11
Digits Only
0409509311
Product NDC
0409-5093
Description
10 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-5093-11) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (0409-5093-14)
Marketing
Marketing Status
Brand
tazicef
Generic
ceftazidime
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "3f749ee0-db14-4ed0-9056-d545a38bbe3b", "openfda": {"unii": ["9M416Z9QNR"], "rxcui": ["1659283", "1659287", "1659292", "1659294"], "spl_set_id": ["9b73979c-c95a-4433-0a9d-f9cea3cb557f"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-5093-11) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (0409-5093-14)", "package_ndc": "0409-5093-11", "marketing_start_date": "20060405"}], "brand_name": "TAZICEF", "product_id": "0409-5093_3f749ee0-db14-4ed0-9056-d545a38bbe3b", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Cephalosporin Antibacterial [EPC]", "Cephalosporins [CS]"], "product_ndc": "0409-5093", "generic_name": "CEFTAZIDIME", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TAZICEF", "active_ingredients": [{"name": "CEFTAZIDIME", "strength": "2 g/1"}], "application_number": "ANDA064032", "marketing_category": "ANDA", "marketing_start_date": "20060405", "listing_expiration_date": "20261231"}